Physician profile
Felipe Rosso
NPI 1538332788
$16,740.10
in general payments reported to CMS, 2019-2025
45 companies · $849 in 2025
The $849 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,126 · 2020: $4,915 · 2021: $696 · 2022: $3,598 · 2023: $755 · 2024: $801 · 2025: $849.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,370 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,370.45 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,919.50 | 2019-2022 | |
| Astellas Pharma US INC | $660.16 | 2019-2024 | Xtandi, Myrbetriq |
| Sumitomo Pharma America, INC. | $443.08 | 2023-2025 | Gemtesa, Orgovyx |
| Janssen Biotech, INC. | $414.68 | 2019-2025 | Erleada, Akeega, Carvykti |
| Pfizer INC. | $392.27 | 2019-2025 | |
| Abbvie INC. | $377.29 | 2019-2025 | |
| Boston Scientific Corporation | $247.74 | 2019-2025 | Upsylon, Greenlight Xps, Ams 700 |
| Urovant Sciences INC | $182.96 | 2021-2022 | |
| Axonics, INC. | $178.81 | 2022-2024 | Bulkamid, Axonics |
| Caldera Medical, INC | $128.38 | 2023 | Desara |
| Healthtronics Stone Solutions, LLC | $124.69 | 2025 | Dornier Medtech, Dornier Medtech, Cvac Aspiration System |
| Tolmar, INC. | $113.99 | 2023-2025 | Jatenzo, Eligard |
| Urogen Pharma, INC. | $112.93 | 2023-2025 | Jelmyto |
| Travere Therapeutics, INC. | $103.85 | 2019-2022 | |
| Antares Pharma, INC. | $99.53 | 2019-2023 | Xyosted, Tlando, Nocdurna |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $94.14 | 2021-2025 | Pylarify |
| Tolmar Pharmaceuticals, INC. | $85.66 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $78.10 | 2021-2024 | Keytruda, Lynparza |
| Dendreon Pharmaceuticals LLC | $70.30 | 2020-2024 | Provenge |
| Allergan, INC. | $66.84 | 2021-2022 | |
| Blue Earth Diagnostics | $62.96 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $61.19 | 2020-2024 | Prolaris |
| 180 Medical, INC. | $60.46 | 2020-2023 | |
| Novartis Pharmaceuticals Corporation | $59.43 | 2022-2023 | |
| Endo Pharmaceuticals INC. | $54.75 | 2021-2023 | Xiaflex |
| Teleflex LLC | $53.67 | 2021-2024 | Urolift |
| Astrazeneca Pharmaceuticals Lp | $52.00 | 2022-2025 | Imfinzi |
| Myovant Sciences INC. | $44.61 | 2021-2022 | |
| Calyxo, INC. | $40.16 | 2024-2025 | Cvac Aspiration System |
| Immunitybio, INC. | $36.14 | 2025 | |
| Valencia Technologies Corporation | $35.52 | 2023-2025 | Ecoin Device Kit |
| Neotract INC. | $32.92 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $28.95 | 2019-2022 | |
| Coloplast Corp | $28.12 | 2020-2021 | |
| Olympus America INC. | $27.78 | 2021-2025 | Itind System |
| Endo USA, INC. | $19.52 | 2024 | Xiaflex |
| Procept Biorobotics Corporation | $19.20 | 2023 | Aquabeam Robotic System |
| Biotissue Holdings INC. | $18.69 | 2023 | |
| Bard Access Systems, INC. | $17.28 | 2019 | |
| Becton, Dickinson and Company | $16.50 | 2024 | Bard Urinary Drainage Bag |
| Photocure INC | $16.34 | 2024 | Cysview |
| Rochester Medical Corporation | $16.05 | 2021 | |
| Medtronic, INC. | $14.96 | 2023 | Interstim |
| Zyla Life Sciences, INC. | $14.54 | 2019 | |
| Laborie Medical Technologies Corp. | $13.46 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Felipe Rosso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.